Work

External validation of a prognostic model for overall survival (OS) in men with metastatic castration-resistant prostate cancer (mCRPC).

Year: 2019

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2019.37.15_suppl.5022

Authors: Susan Halabi, Sandipan Dutta, John C. Araujo, Christopher Logothetis, Cora N. Sternberg, Andrew J. Armstrong, Michael Anthony Carducci, Kim N. Chi, Johann S. De Bono, Daniel Peter Petrylak, Karim Fizazi, Celestia S. Higano, Eric Jay Small, William Kevin Kelly

Institutions: Duke Medical Center, Duke University, The University of Texas MD Anderson Cancer Center, Weill Cornell Medicine, Duke Cancer Institute, Sidney Kimmel Comprehensive Cancer Center, BC Cancer Agency, Royal Marsden NHS Foundation Trust, Institute of Cancer Research, Yale University, Université Paris-Sud, Institut Gustave Roussy, University of Washington, Fred Hutch Cancer Center, UCSF Helen Diller Family Comprehensive Cancer Center, Thomas Jefferson University, Sidney Kimmel Cancer Center

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2947242075

Cites:

Cited by:

Related to: 10